Switching thrombopoietin receptor agonist treatments in patients with primary immune thrombocytopenia

Primary immune thrombocytopenia (ITP) is a bleeding disorder that conventionally has been treated with steroids or other immunosuppressive treatments. The introduction of thrombopoietin receptor agonists (TPO-RAs), which increase platelet production, dramatically changed the treatment landscape for...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Porras, José R., Godeau, Bertrand, Carpenedo, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review/Drug review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515841/
https://www.ncbi.nlm.nih.gov/pubmed/31156798
http://dx.doi.org/10.1177/2040620719837906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515841/
https://www.ncbi.nlm.nih.gov/pubmed/31156798
http://dx.doi.org/10.1177/2040620719837906

Ejemplares similares